{
    "clinical_study": {
        "@rank": "28466", 
        "arm_group": [
            {
                "arm_group_label": "Control", 
                "arm_group_type": "Placebo Comparator", 
                "description": "macro- and micro-nutrient matched control (240 ml)"
            }, 
            {
                "arm_group_label": "Orange juice", 
                "arm_group_type": "Experimental", 
                "description": "commercial orange juice (240 ml)"
            }, 
            {
                "arm_group_label": "whole orange", 
                "arm_group_type": "Experimental", 
                "description": "whole orange fruit (240 ml)"
            }, 
            {
                "arm_group_label": "processed whole orange", 
                "arm_group_type": "Experimental", 
                "description": "processed whole orange (240 ml)"
            }
        ], 
        "brief_summary": {
            "textblock": "Acute, randomized, placebo controlled, double blind, postprandial crossover study in male\n      subjects. 4 intervention arms consisting of control, orange juice, whole orange, and\n      processed whole orange to determine the effect of the interventions on the primary measure\n      of flow mediated dilatation (FMD) and additional biomarkers of health.  The study will also\n      identify and quantify the main micronutrients and phytochemicals in each of the products and\n      will identify and quantify the main micronutrients and phytochemicals and their metabolites\n      in the subjects' plasma and/or urine. A subset of the study population (n=24) will be\n      invited to participate in an additional arm of the main study which is summarised below."
        }, 
        "brief_title": "Effects of Fruit Consumption on Risk Factors of Chronic Disease", 
        "completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "condition": "Vascular Stiffness", 
        "condition_browse": {
            "mesh_term": "Chronic Disease"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Males due to potential hormonal fluctuations in female subjects\n\n          -  Aged 30-65years\n\n          -  Fasting total cholesterol in the upper half of the normal range (6.0-8.0 mmol/l) or\n             triacylglycerol >0.8 mmol/l or a BMI 25-32 kg/m2.\n\n          -  Not having suffered a myocardial infarction/stroke in the past 12 months\n\n          -  Not diabetic (diagnosed or fasting glucose > 7 mmol/l) or suffer from other endocrine\n             disorders\n\n          -  Not suffering from renal or bowel disease or have a history of choleostatic liver or\n             pancreatitis\n\n          -  Not on drug treatment for hyperlipidaemia, hypertension, inflammation or\n             hypercoagulation\n\n          -  No history of alcohol misuse\n\n          -  Not planning or on a weight reducing regime\n\n          -  Not taking any fish oil, fatty acid or vitamin and mineral supplements\n\n          -  Non smokers\n\n          -  Not suffering from depression as indicated by the Brief Symptom Inventory (Appendix\n             11).\n\n          -  Not suffering from mild cognitive impairment or dementia according to the MMSE (score\n             \u2265 25).\n\n        Exclusion Criteria:\n\n          -  Females\n\n          -  Medication for hypertension, hyperlipidaemia, inflammation or hypercoagulation\n\n               -  Hypertension - ACE Inhibitors (e.g. Captopril, Cilazapril), Angiotensin Receptor\n                  Blockers (Valsartan), Calcium Channel Blockers (Amlodipine, Nicardipine),\n                  Diuretics (Chlortalidone) or Beta blockers (Sotalol, Bisoprolol).\n\n               -  Cholesterol lowering (Pravastatin, Simuvustatin)\n\n               -  Anticoagulants (Warfarin)\n\n               -  Inflammation - NSAID's (Tiaprofenic acid, Sulindac, Ibuprofen),\n                  Corticosteroids(Betamethasone)\n\n          -  Strict vegetarians\n\n          -  Smokers\n\n          -  Those on or planning a weight reducing regime\n\n          -  Blood  glucose, haemaglobin or liver enzymes outside of the normal range\n\n          -  Unable to consume study meals\n\n          -  Those suffering from depression as indicated by the Brief Symptom Inventory (Appendix\n             11).\n\n          -  Those suffering from mild cognitive impairment or dementia as indicated by the MMSE\n             (score < 25)."
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "34", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01963416", 
            "org_study_id": "UOR-0001"
        }, 
        "intervention": [
            {
                "arm_group_label": "Control", 
                "intervention_name": "macro- and micro-nutrient matched control (240 ml)", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Orange juice", 
                "intervention_name": "Orange juice", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "whole orange", 
                "intervention_name": "whole orange fruit", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "processed whole orange", 
                "intervention_name": "Processed whole orange", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Micronutrients", 
                "Trace Elements"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 11, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Reading", 
                    "country": "United Kingdom", 
                    "state": "Berkshire", 
                    "zip": "RG2 9AR"
                }, 
                "name": "University of Reading"
            }
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "4", 
        "official_title": "A Randomized Controlled, Crossover in Design, Double Blind Clinical Trial Investigating the Effects of Whole Versus Processed Fruit Consumption on Risk Factors for Chronic Disease and Performance Indicators.", 
        "other_outcome": {
            "measure": "Plasma flavanone metabolites", 
            "safety_issue": "No", 
            "time_frame": "change from baseline to 6 hours"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United Kingdom: Research Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Flow mediated dilation", 
            "safety_issue": "No", 
            "time_frame": "change in Flow Mediated Dilation response between baseline and 6 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01963416"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Reading", 
            "investigator_full_name": "Jeremy Paul Edward Spencer", 
            "investigator_title": "Professor of Nutritional Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Postprandial plasma glucose", 
                "safety_issue": "No", 
                "time_frame": "change in glucose from baseline to 2 hours"
            }, 
            {
                "measure": "Postprandial insulin", 
                "safety_issue": "No", 
                "time_frame": "change from baseline to 2 hours"
            }, 
            {
                "measure": "global cognitive function", 
                "safety_issue": "No", 
                "time_frame": "change from baseline to 6 hours"
            }, 
            {
                "measure": "Blood pressure", 
                "safety_issue": "No", 
                "time_frame": "change from baseline to 6 hours"
            }, 
            {
                "measure": "postprandial non-esterified fatty acids", 
                "safety_issue": "No", 
                "time_frame": "change from baseline to 6 hours"
            }, 
            {
                "measure": "Postprandial triacylglycerol", 
                "safety_issue": "No", 
                "time_frame": "change from baseline to 6 hours"
            }, 
            {
                "measure": "total HDL/LDL", 
                "safety_issue": "No", 
                "time_frame": "change from baseline to 6 hours"
            }, 
            {
                "measure": "Inflammatory status (IL1-beta; IL2; IL6; IL10; IFN-gamma; TNF-alpha; CRP)", 
                "safety_issue": "No", 
                "time_frame": "change from baseline to 6 hours"
            }, 
            {
                "measure": "LDL oxidation", 
                "safety_issue": "No", 
                "time_frame": "change from baseline to 6h"
            }
        ], 
        "source": "University of Reading", 
        "sponsors": {
            "collaborator": {
                "agency": "PepsiCo Global R&D", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "University of Reading", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}